Under auspices of the EPCCS we have several educational programs developed. Compact 10 minute lectures by international experts on various topics
"During the pandemic, we have lost sight of long-term conditions that are the biggest contributors to worse outcomes", says prof. Hobbs. "We need to restart and catch up in CVD prevention ASAP."
EPCCS 2018 Three professors discuss how best to measure blood pressure, when to call it hypertension, and once hypertension is diagnosed, what BP target to aim for, based on the latest scientific insights.
EPCCS 2018 Management of heart failure is complex, as it often concerns elderly patients who have comorbidities. Good cooperation between primary and secondary care can benefit these patients.
EPCCS 2018 Despite the known efficacy of lipid-lowering therapy, in clinical reality still many patients remain at high risk, for instance due to statin intolerance. The panel discusses how to manage this, and also which risk assessment tools can be used in which patients, to guide treatment decisions.
In his presentation, prof. Cos considered recent observations that novel classes of antidiabetic drugs can provide CV benefit in T2DM patients. Cos, Brotons and Hobbs discuss how this can improve management and outcomes of these patients.
EPCCS 2017 Prof. Richard McManus summarises the results of three large trials that evaluated different intensities of blood pressure management and different blood pressure targets. With prof. Richard Hobbs, he considers what lessons can be learned for primary care.
EPCCS 2017 Dr. Clare Taylor and dr. Arno Hoes discuss the major changes in the latest ESC HF Guidelines and summarise what they learned from the discussion about HF management in different countries.
EPCCS 2017 Dr. Frans Rutten and dr. Carlos Brotons summarise the latest updates in the ESC guidelines on dyslipidaemia, relevant for the GP, and summarise the discussion this presentation sparked among the EPCCS audience.
EPCCS 2017 In their summary of the EPCCS session on behaviour change, dr. Monika Hollander and prof. Christi Deaton highlight which techniques to help patients improve risk behaviour can be employed.
Prof. Richard Hobbs (Oxford, UK) and Prof. Paul Aveyard (Oxford, UK) discuss the evidence base of effectiveness of health behaviour changes and how GPs can best play a role in stimulating a patient to engage in lifestyle modifications to reduce their CV risk.
Richard McManus (Oxford, UK) and Monika Hollander (Utrecht, The Netherlands) discuss which blood pressure measurement method is best to identify true hypertension in primary care and how this should be treated.
Richard Hobbs (Oxford, UK) and Arno Hoes (Utrecht, The Netherlands) summarise the lively discussion after Hoes' talk on dilemmas in lipid-lowering in primary care.
